The National Institute for Health and Clinical Excellence have just launched two new products to help with medicines management and prescribing.
Evidence summaries: unlicensed/off-label medicines review the best available evidence for selected unlicensed and off-label medicines where there are no clinically appropriate licensed alternatives.
Evidence summaries: unlicensed/off-label medicines review the best available evidence for selected unlicensed and off-label medicines where there are no clinically appropriate licensed alternatives.
Evidence summaries: new medicines are provided to help make informed decisions and aid local planning on the introduction of key new medicines or existing medicines with new indications or a new formulation. The topics selected are medicines that have recently gone into the UK market, or may be marketed in the UK in the next 6-12 months.
They both offer quality-assured summaries of the best available evidence for selected medicines. The strengths and weaknesses of the relevant evidence are critically reviewed, but the summaries do not constitute formal NICE guidance.
No comments:
Post a Comment